News

Aeva Technologies, Inc. Chief Executive Officer Soroush Salehian Dardashti filed a Form 4 on November 6, 2026, disclosing the automatic sale of 42,262 shares of common stock on November 5, 2026, to cover tax withholding obligations upon the settlement of restricted stock unit awards.

Aeva Technologies, Inc. Chief Technology Officer and Director Mina Rezk filed a Form 4 on November 6, 2026, disclosing the automatic sale of 28,173 shares of common stock on November 5, 2026, to cover tax withholding obligations upon the settlement of time-based restricted stock …

Director Vyacheslav Kim of Joint Stock Co Kaspi.kz filed a Form 4 on November 6, 2026, disclosing the sale of American Depositary Shares across eleven transactions conducted between November 4 and November 6, 2026, pursuant to a Rule 10b5-1 plan.

Philip G. Brace, CEO and President of Skyworks Solutions, Inc., filed a Form 4 on November 6, 2026, reporting multiple transactions in the company's common stock on November 5, 2026, including the vesting of restricted stock units and the issuance of shares under a …

Steven D. Conly, Senior Vice President, Waters Biosciences at Waters Corp /DE/, filed an initial statement of beneficial ownership (Form 3) on November 6, 2026, reporting securities held as of the event date of October 29, 2026.

ARCH Venture Partners and affiliated entities filed Amendment No. 8 to their Schedule 13D with the SEC on November 6, 2026, disclosing share sales in Vir Biotechnology, Inc. common stock between November 3 and November 5, 2026.

Morgan Stanley and Parametric Portfolio Associates LLC filed Amendment No. 3 to a Schedule 13G on November 6, 2026, disclosing their beneficial ownership of Common Shares of Beneficial Interest in Western Asset Inflation-Linked Opportunities & Income Fund as of September 30, 2026.